These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3370824)

  • 1. Newborn screening for cystic fibrosis using an enzyme linked immunoabsorbent assay (ELISA) technique.
    Bowling FG; Brown AR
    Clin Chim Acta; 1988 Feb; 171(2-3):257-61. PubMed ID: 3370824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody-based enzyme immunoassay for trypsinogen in neonatal screening for cystic fibrosis.
    Bowling FG; Watson AR; Rylatt DB; Elliott JE; Bunch RJ; Bundesen PG
    Lancet; 1987 Apr; 1(8537):826-7. PubMed ID: 2882233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots.
    Crossley JR; Smith PA; Edgar BW; Gluckman PD; Elliott RB
    Clin Chim Acta; 1981 Jun; 113(2):111-21. PubMed ID: 7249357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody against human trypsin: production, characterization, and use for diagnosis.
    Acosta Bas C; Baluja Conde IB; Brito Moreno AI; Rodríguez López MR; Melchor A; Hernández L; Frómeta A; Selles ME; Martínez L
    Hybrid Hybridomics; 2002 Dec; 21(6):487-90. PubMed ID: 12573113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive trypsin assay for dried-blood specimens as a screening procedure for early detection of cystic fibrosis.
    King DN; Heeley AF; Walsh MP; Kuzemko JA
    Lancet; 1979 Dec; 2(8154):1217-9. PubMed ID: 92625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive trypsin screening for cystic fibrosis.
    Borgström A; Sveger T; Lindberg T; Kollberg H; Larsson A
    Acta Paediatr Scand; 1982 Jul; 71(4):621-4. PubMed ID: 7136678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neonatal detection of cystic fibrosis by measurement of immunoreactive trypsin in blood.
    Heeley AF; Bangert SK
    Ann Clin Biochem; 1992 Jul; 29 ( Pt 4)():361-76. PubMed ID: 1642442
    [No Abstract]   [Full Text] [Related]  

  • 8. Neonatal screening for cystic fibrosis by dried blood spot trypsin assay. Results in 47 127 newborn infants from a homogeneous population.
    Cassio A; Bernardi F; Piazzi S; Capelli M; Frejaville E; Villa MP; Martelli E; Balsamo A; Salardi S; Merighi R
    Acta Paediatr Scand; 1984 Jul; 73(4):554-8. PubMed ID: 6464744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dried-blood spot screening for cystic fibrosis in the newborn.
    Crossley JR; Elliott RB; Smith PA
    Lancet; 1979 Mar; 1(8114):472-4. PubMed ID: 85057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening of newborn infants for cystic fibrosis. A combined analysis of immunoreactive trypsin and delta F508 mutation--a screening without false positive results].
    Nørgaard-Pedersen B; Høgdall EV; Arends J; Vuust J
    Ugeskr Laeger; 1994 Jun; 156(25):3757-60. PubMed ID: 8059453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay of serum immunoreactive trypsin in dried blood spots and the early detection of cystic fibrosis.
    Ryley HC; Robinson PG; Yamashiro Y; Bradley DM
    J Clin Pathol; 1981 Aug; 34(8):906-10. PubMed ID: 7276210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a dried blood spot in immunoreactive-trypsin assay for detection of cystic fibrosis in infants.
    Kirby LT; Applegarth DA; Davidson AG; Wong LT; Hardwick DF
    Clin Chem; 1981 May; 27(5):678-8. PubMed ID: 7226492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mucoviscidosis screening by determination of immunoreactive trypsin].
    Sander J; Niehaus C
    Klin Padiatr; 1984; 196(4):224-7. PubMed ID: 6482307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for cystic fibrosis by died blood spot trypsin assay.
    Heeley AF; Heeley ME; King DN; Kuzemko JA; Walsh MP
    Arch Dis Child; 1982 Jan; 57(1):18-21. PubMed ID: 7039516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silica nanoparticle-based microfluidic immunosensor with laser-induced fluorescence detection for the quantification of immunoreactive trypsin.
    Seia MA; Stege PW; Pereira SV; De Vito IE; Raba J; Messina GA
    Anal Biochem; 2014 Oct; 463():31-7. PubMed ID: 24983904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of 4 neonatal screening strategies for cystic fibrosis.
    van den Akker-van Marle ME; Dankert HM; Verkerk PH; Dankert-Roelse JE
    Pediatrics; 2006 Sep; 118(3):896-905. PubMed ID: 16950979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pancreatitis-associated protein (PAP). A new candidate for neonatal screening of cystic fibrosis.
    Iovanna JL; Férec C; Sarles J; Dagorn JC
    C R Acad Sci III; 1994 Jun; 317(6):561-4. PubMed ID: 7527291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for cystic fibrosis.
    Lyon IC; Crossley JR; Smith PA
    N Z Med J; 1983 Sep; 96(739):673-5. PubMed ID: 6577337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for cystic fibrosis among newborns in Norway by measurement of serum/plasma trypsin-like immunoreactivity. Results of a 2 1/2-year pilot project.
    Edminson PD; Michalsen H; Aagenaes O; Lie SO
    Scand J Gastroenterol Suppl; 1988; 143():13-8. PubMed ID: 3164498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal screening for cystic fibrosis: France rises to the challenge.
    Farriaux JP; Vidailhet M; Briard ML; Belot V; Dhondt JL
    J Inherit Metab Dis; 2003; 26(8):729-44. PubMed ID: 14739679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.